COMP <GO>
BKV vs CTRI // REVENUE GROWTH (YOY)
BKV Corporation (NYSE) VS. Centuri Holdings Inc. (NYSE) • 15-METRIC TALLY: BKV 7
— CTRI 3
▲ REVENUE GROWTH (YOY) LEADER: BKV
LAST: $20.94 (-1.09%) • MKT CAP: $2.29B
revenue-growth
41.60%
LAST: $21.54 (+2.67%) • MKT CAP: $2.17B
revenue-growth
13.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BKV VS. CTRI)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | BKV | CTRI | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 8.30% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.00% | 5.00% | +4.00 | BKV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 5.3x | 16.6x | -11.30 | BKV | /valuation <GO> |
| Free Cash Flow Yield | -1.08% | -0.38% | -0.70 | CTRI | /fcf-yield <GO> |
| Operating Margin | 26.60% | 3.10% | +23.50 | BKV | /operating-margins <GO> |
| Net Profit Margin | 15.70% | 0.80% | +14.90 | BKV | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 41.60% | 13.10% | +28.50 | BKV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 1.37 | 2.34 | -0.97 | CTRI | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.1 | 60.6 | -21.50 | CTRI | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 10.8x | 81.6x | -70.80 | BKV | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.29B | $2.17B | $116.9M | BKV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | BKV REV | CTRI REV | BKV GROSS % | CTRI GROSS % | BKV FCF | CTRI FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.14B | $2.98B | — | 8.3% | -$24.7M | -$8.2M |
| FY 2024 | $805.7M | $2.64B | — | 8.4% | $10.0M | $58.9M |
| FY 2023 | $1.01B | $2.90B | — | — | $260.3M | $167.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BKV // BETA —
CTRI // BETA —